Related / Contacts
Related / News
Recipharm divests bioanalysis business to Center for Translational Research AB further strengthening existing partnership with CTC Clinical Trial Consultants AB
Press releases • Nov 01, 2019 11:08 UTC
Recipharm, the contract development and manufacturing organisation, and CTC Clinical Trial Consultants have strengthened their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research AB (CTR) group. CTR is the Uppsala based parent company of CTC Clinical Trial Consultants.